FRONTEO,Inc. (2158)

Market cap
¥22.9B
P/E ratio
152.4x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndShort-term debt (Million JPY)YoY (%)
Mar 31, 20262,600+160.00%
Mar 31, 20251,000-16.67%
Mar 31, 20241,200+140.00%
Mar 31, 2023500-64.29%
Mar 31, 20211,400-12.50%
Mar 31, 20201,600+45.45%
Mar 31, 20191,100-26.67%
Mar 31, 20181,500+50.00%
Mar 31, 20171,000+1823.08%
Mar 31, 201652+44.44%
Mar 31, 201536
AI Chat